Cholesterol drug could be new weapon against deadly blood clots
NCT ID NCT04319627
Summary
This large Phase 3 trial is testing whether adding the cholesterol-lowering drug rosuvastatin to standard blood thinners can help prevent dangerous blood clots from returning. The study will enroll 2,700 adults who recently had a major leg or lung clot, giving half the participants the statin and half a placebo pill alongside their usual treatment. Researchers hope this common medication might provide extra protection by reducing vein inflammation and preventing new clots from forming.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
APHP Hôpital Louis Mourier
RECRUITINGColombes, France
Contact
-
Aberdeen Royal Infirmary
NOT_YET_RECRUITINGAberdeen, United Kingdom
Contact
-
Brest University Hospital Centre
RECRUITINGBrest, France
Contact
-
CHI Toulon - La Seyne sur Mer - Hôpital Sainte Musse
RECRUITINGToulon, France
Contact
-
CHU d'Angers - Service d'accueil et traitement des Urgences
RECRUITINGAngers, France
Contact
-
CHU de Clermont-Ferrand, Hôpital Gabriel Montpied
RECRUITINGClermont-Ferrand, France
Contact
-
CHU de Dijon - Service d'imagerie diagnostique et thérapeutique
RECRUITINGDijon, France
Contact
-
CHU de Quebec-Université Laval
RECRUITINGQuébec, Quebec, G1V 4G2, Canada
Contact
-
CIUSSS de-l'Ouest-de-l'Ile-de-Montreal -St. Mary's Hospital Center
RECRUITINGMontreal, Quebec, H9R 2Y2, Canada
Contact
-
Centre Hospitalier Universitaire De Saint Etienne
RECRUITINGSaint-Etienne, France
Contact
-
Foothills Medical Centre
RECRUITINGCalgary, Alberta, T2N 2T9, Canada
Contact
-
GH La Rochelle - Ré-Aunis - Service de Médecine vasculaire
RECRUITINGLa Rochelle, France
Contact
-
Glasgow Royal Infirmary
NOT_YET_RECRUITINGGlasgow, United Kingdom
Contact
-
Hamilton General Hospital
RECRUITINGHamilton, Ontario, L8L 2X2, Canada
Contact
-
Hôpital Montfort
WITHDRAWNOttawa, Ontario, K1K 0T2, Canada
-
Jewish General Hospital
RECRUITINGMontreal, Quebec, H3T 1E2, Canada
Contact
-
Juravinski Hospital
WITHDRAWNHamilton, Ontario, L8V 1C3, Canada
-
King's College Hospital NHS Foundation Trust
NOT_YET_RECRUITINGLondon, United Kingdom
Contact
-
Mater Misericordiae University Hospital
NOT_YET_RECRUITINGDublin, Ireland
Contact
-
McGill Univeristy Health Centre
RECRUITINGMontreal, Quebec, H4A 3J1, Canada
Contact
-
Niagara Health - St. Catharines Site
RECRUITINGSt. Catharines, Ontario, L2S 0A9, Canada
Contact
-
Ostfold Hopsital
RECRUITINGSarpsborg, Norway
Contact
Contact
-
Oxford University Hospitals NHS Foundation Trust
NOT_YET_RECRUITINGOxford, United Kingdom
Contact
-
Queen Elizabeth Hospital
NOT_YET_RECRUITINGBirmingham, United Kingdom
Contact
-
Queen Elizabeth II Hospital
WITHDRAWNHalifax, Nova Scotia, B3H 2Y9, Canada
-
St. Joseph's Healthcare
RECRUITINGHamilton, Ontario, L8N 4A6, Canada
Contact
-
Sunnybrook Hospital
NOT_YET_RECRUITINGToronto, Ontario, M4N 3M5, Canada
Contact
-
The Ottawa Hospital
RECRUITINGOttawa, Ontario, K1H 8L6, Canada
Contact
Contact Email: •••••@•••••
-
University Health Network
RECRUITINGToronto, Ontario, M5G 2C4, Canada
Contact
-
University Hospital of Wales
NOT_YET_RECRUITINGCardiff, United Kingdom
Contact
-
University of Insubria
NOT_YET_RECRUITINGVarese, Italy
Contact
Conditions
Explore the condition pages connected to this study.